Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
3(27%)
Results Posted
150%(3 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
10
91%
Ph phase_3
1
9%

Phase Distribution

0

Early Stage

10

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
10(90.9%)
Phase 3Large-scale testing
1(9.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

2 of 6 finished

Non-Completion Rate

66.7%

4 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(2)
Terminated(4)
Other(1)

Detailed Status

Withdrawn3
Recruiting3
Completed2
Not yet recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 210 (90.9%)
Phase 31 (9.1%)

Trials by Status

withdrawn327%
recruiting327%
not_yet_recruiting19%
terminated19%
completed218%
unknown19%

Recent Activity

3 active trials
Showing 5 of 11
not_yet_recruitingphase_2

4AP for Carpal Tunnel Syndrome (CTS)

NCT06294821
recruitingphase_2

4-aminopyridine Treatment for Nerve Injury

NCT03701581
recruitingphase_2

4-aminopyridine for Skin Wound Healing

NCT06333171
recruitingphase_2

4-AP Peripheral Nerve Crossover Trial

NCT06003166
completedphase_2

Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients

NCT01645787
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06294821Phase 2

4AP for Carpal Tunnel Syndrome (CTS)

Not Yet Recruiting
NCT03701581Phase 2

4-aminopyridine Treatment for Nerve Injury

Recruiting
NCT06333171Phase 2

4-aminopyridine for Skin Wound Healing

Recruiting
NCT06003166Phase 2

4-AP Peripheral Nerve Crossover Trial

Recruiting
NCT01645787Phase 2

Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients

Completed
NCT03578354Phase 2

4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine

Withdrawn
NCT04026568Phase 2

A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma

Terminated
NCT03899584Phase 3

High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients.

Unknown
NCT01543750Phase 2

4-Aminopyridine in Episodic Ataxia Type 2

Withdrawn
NCT02280096Phase 2

Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis

Completed
NCT03658408Phase 2

4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy

Withdrawn

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11